WHO OWNS YOUR DNA NOW? Regeneron Buys 23andMe in $256 Million Deal Amid Mounting Fears Over Genetic Privacy Bioethics
GENETIC ASSETS FOR SALE: The 23andMe Bankruptcy Could Become a Trojan Horse for China Biotech & Surveillance
Data Can’t Be Replaced: FTC Warns Any Buyer of 23andMe Must Honor Genetic Privacy Promises Biotech Ethics
